CliffBio
biologic

Palforzia

Peanut (Arachis hypogaea) Allergen Powder-dnfp

Loss of exclusivityJanuary 2032projected — 12-year biologic exclusivity estimate
CompanyGreer Laboratories →View the full company profile on CliffBio

Drug detail

Brand namePalforzia
Active ingredientPeanut (Arachis hypogaea) Allergen Powder-dnfp
Strength100MG
Dosage formPowder
RouteOral
ModalityBiologic
FDA approvalJanuary 2020
Marketing statusRx

More from Greer Laboratories

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Palforzia patent cliff — loss of exclusivity January 2032 | CliffBio